Best Revascularization Strategy in Patients with Left Ventricular Deterioration

Multivessel disease associated to ventricular function deterioration is challenging in terms of risk, when choosing a revascularization strategy. 

La mejor revascularización en pacientes con deterioro del ventrículo izquierdo

According to this recent analysis of the SCAAR registry published in the European Heart Journal, long term followup seems to justify taking a higher risk initially, higher risk being myocardial revascularization surgery (CABG).

The study looked at all cause death in patients receiving CABG vs PCI presenting cardiac failure due to ventricular function deterioration and multivessel disease (>50% angiographic lesion in at least 2 vessels or in left main).

Propensity score was used to compare populations, which resulted in a total of 2509 patients; 35.8% presented diabetes and a similar percentage had prior MI history. Mean age was 68.1 ± 9.4 years with nearly half the population over 70, and most had lesions in 3 vessels or in the left main. 

Patients were initially treated with PCI (56.2%) and surgery (43.8% of the population). 


Read also: The Role of Aspirin after the TWILIGHT-ACS.


After mean followup of four years (some reached 10) mortality resulted lower in the surgery group (OR 0.62; CI 95% 0.41 to 0.96; p=0.031). However, this increased linearly in centers where PCI was the preferred revascularization strategy. 

Conclusion

In the long term, patients with ischemic heart failure will benefit from the surgical revascularization strategy. 

ehab273

Original Title: Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Reference: Sebastian Völz et al. European Heart Journal (2021) 42, 2657–2664 doi:10.1093/eurheartj/ehab273.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...